A new study published in JAMA Network Open explores the risk for smoking presented by childhood trauma with subsequent failure of emotional regulation and the neural measures that reflect these risk factors.
Dewpoint Therapeutics restructures to ‘make room’ for entry into the clinic next year in oncology, ALS
Condensate modulator startup Dewpoint Therapeutics is going through a restructuring as it gears up for its first clinical trials next year in colorectal cancer and
January 18, 2024